VRXA
Veraxa Biotech AG
1.30$
-4.6%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
Veraxa Biotech AG (VRXA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -9.9 million CHF. Tick rows to compare them in a chart.
All figures in millions of CHF.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| -7.3 | -7.7 | -9.9 | |
| 1.9 | 1.9 | 2.0 | |
| 7.6 | 18 | 53 | |
| -0.7 | 0.4 | 1.2 | |
| 0.2 | 0.1 | 0.4 | |
| – | 0.0 | 0.8 | |
| 13 | 1.9 | 6.6 | |
| 4.3 | -6.0 | -3.7 | |
| -7.5 | -7.8 | -10 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.